Medical treatment of benign prostatic hyperplasia: 5 alpha-reductase inhibitors and alpha-adrenergic antagonists.
Monda, J M
Medical treatment of benign prostatic hyperplasia: 5 alpha-reductase inhibitors and alpha-adrenergic antagonists. [electronic resource] - Mayo Clinic proceedings Jul 1993 - 670-9 p. digital
Publication Type: Journal Article; Review
0025-6196
10.1016/s0025-6196(12)60603-x doi
5-alpha Reductase Inhibitors
Adrenergic alpha-Antagonists--adverse effects
Aged
Aged, 80 and over
Androstenes--adverse effects
Azasteroids--adverse effects
Finasteride
Humans
Male
Prostatic Hyperplasia--drug therapy
Medical treatment of benign prostatic hyperplasia: 5 alpha-reductase inhibitors and alpha-adrenergic antagonists. [electronic resource] - Mayo Clinic proceedings Jul 1993 - 670-9 p. digital
Publication Type: Journal Article; Review
0025-6196
10.1016/s0025-6196(12)60603-x doi
5-alpha Reductase Inhibitors
Adrenergic alpha-Antagonists--adverse effects
Aged
Aged, 80 and over
Androstenes--adverse effects
Azasteroids--adverse effects
Finasteride
Humans
Male
Prostatic Hyperplasia--drug therapy